Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Negri

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Journal of Cancer Research and Clinical Oncology|November 7, 2019
Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patientsVincenzo Catalano, Francesca Bergamo, Chiara Cremolini, et al.
Journal of Thoracic Disease|November 10, 2017
Pulmonary metastasectomy for colorectal cancer: analysis of prognostic factors affecting survivalLuca Ampollini, Letizia Gnetti, Matteo Goldoni, et al.
Frontiers in Oncology|March 17, 2023
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology?Francesca Negri, Lorena Bottarelli, Giuseppe Pedrazzi, et al.
Pediatric Blood & Cancer|May 1, 2015
Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma groupKatia Mazzocco, Raffaella Defferrari, Angela Rita Sementa, et al.
European Journal of Cancer (Oxford, England : 1990)|April 3, 2021
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trialStefano Cascinu, Rossana Berardi, Roberto Bianco, et al.
The Lancet. Oncology|April 8, 2018
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled studyLorenza Rimassa, Eric Assenat, Markus Peck-Radosavljevic, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2019
A validated prognostic classifier for <sup>V600E</sup>BRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' studyFotios Loupakis, Rossana Intini, Chiara Cremolini, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Journal of Cancer Research and Clinical Oncology|November 7, 2019
Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patientsVincenzo Catalano, Francesca Bergamo, Chiara Cremolini, et al.
Journal of Thoracic Disease|November 10, 2017
Pulmonary metastasectomy for colorectal cancer: analysis of prognostic factors affecting survivalLuca Ampollini, Letizia Gnetti, Matteo Goldoni, et al.
Frontiers in Oncology|March 17, 2023
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology?Francesca Negri, Lorena Bottarelli, Giuseppe Pedrazzi, et al.
Pediatric Blood & Cancer|May 1, 2015
Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma groupKatia Mazzocco, Raffaella Defferrari, Angela Rita Sementa, et al.
European Journal of Cancer (Oxford, England : 1990)|April 3, 2021
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trialStefano Cascinu, Rossana Berardi, Roberto Bianco, et al.
The Lancet. Oncology|April 8, 2018
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled studyLorenza Rimassa, Eric Assenat, Markus Peck-Radosavljevic, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2019
A validated prognostic classifier for <sup>V600E</sup>BRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' studyFotios Loupakis, Rossana Intini, Chiara Cremolini, et al.
Pageof 7